Equifax Inc. EFX
Composite 48/100; the shares have moved about 40% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Momentum ranks 28/100 — a moderate mark against it.
Quality ranks 62/100 — a slight point in its favour. Growth ranks 59/100 — a slight point in its favour.
Momentum ranks 28/100 — a moderate mark against it. Valuation ranks 37/100 — a moderate mark against it. Balance-sheet strength ranks 46/100 — a slight mark against it.
What the company does Equifax Inc. (EFX) provides data, analytics, and technology solutions across Workforce Solutions, U.S. Information Solutions (USIS), and International segments. Workforce Solutions verifies employment and income data for HR and payroll processes. USIS offers credit information, fraud detection, identity verification, and consulting services. The International segment provides consumer and commercial credit services globally.
Key financials EFX reports ROE 14.3%, ROA 6.2%, and ROCE 12.4%. Gross, operating, and net margins are 55.5%, 17.3%, and 10.7%, respectively. Revenue and EPS growth are 6.9% and 10.1%. Debt/Equity is 1.21, net debt/EBITDA 2.75, and interest coverage 5.23. Dividend yield is 1.2% with a payout ratio of 26.5%.
Stock health EFX scores 47.5/100 overall (Average quality, fairly valued, weak momentum). Quality (61.9) and Growth (58.6) are above average, while Momentum (27.7) and Valuation (37.3) lag. Piotroski F-Score is 7/9 and Altman Z is 3.33, indicating moderate financial strength. Current ratio is 0.60, below 1.0.
Price vs fair value EFX trades at a **discount of 13.60%** to the analyst mean target of 211.52. - EFX gains from data advantage and innovations amid refinancing risks (2026-09-02) - Dividend analysis highlights sustainability (2026-08-31) - Settlement news may weigh on sentiment (2026-08-29) - Stock index futures lower amid geopolitical tensions (2026-08-31)
Looking forward Forward P/E of 22.57 and PEG of 0.47 suggest improving earnings relative to price. Revenue growth of 6.9% and EPS growth of 10.1% indicate steady performance. Valuation metrics (P/E 33.46, EV/EBITDA 14.49) remain elevated but show improvement from current levels. Momentum remains weak with -23.38% over 12 months.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.